Literature DB >> 24499260

Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.

Roxanna M Bendixen1, Donovan J Lott, Claudia Senesac, Sunita Mathur, Krista Vandenborne.   

Abstract

PURPOSE: While most studies of Duchenne muscular dystrophy (DMD) have focused on physical impairment, there is a need to explore how impairment impacts real-life experiences in order to provide intervention strategies focused on participation. Objectives were: (1) to investigate the domains of participation in a sample of boys with DMD; (2) to compare a younger (<10 years) and older (≥10 years) group of boys with DMD with regard to participation; (3) to investigate strength and timed functional tests in a sample of boys with DMD; (4) to compare a younger (<10 years) and older (≥10 years) group of boys with DMD with regard to strength and timed functional tests; and (5) to explore associations between participation and strength and timed functional tests for our DMD cohorts.
METHODS: This cross-sectional study included 60 boys with DMD (mean 9.3 years ± 0.3). Boys completed strength testing, timed functional tests, the Children's Assessment of Participation and Enjoyment and the ACTIVLIM. Independent samples t-tests were used to test for differences in all measures between our younger and older cohorts; Spearman's (rank) correlation was used to assess relationships between participation and strength and time functional tests.
RESULTS: Significant differences were found between our younger and older boys with DMD in the areas of recreational (p < 0.01), social (p < 0.001), and skill-based activities (p < 0.05), as well as with whom and where the activities were performed (p < 0.05 and 0.001, respectively). Older boys with DMD report lower levels of participation in these areas, as well as less engagement in activities with individuals other than family members and less participation outside of the home. Lower levels of strength and slower rates of functional performance correlate with participation in fewer physical activities for our younger cohort and fewer physical and social activities for our older cohort.
CONCLUSIONS: Strength and function relate to the variability and type of activities in which boys with DMD participate. A key finding is the significant decline in social activities and community-based engagement as the boys with DMD age. The ultimate goal of an intervention is for our children to be as actively engaged in life as they desire. This requires addressing participation when measuring outcomes in order to more fully understand limitations and provide appropriate strategies for continued participation for boys and their families. IMPLICATIONS FOR REHABILITATION: Duchenne muscular dystrophy is a devastating progressive neuromuscular disorder that leads to significant strength and functional limitations, which affect physical and social participation for these boys. The ability to move beyond clinically-based outcomes and assess and monitor a child's daily activities through participation measures may provide information for therapeutic interventions. Rehabilitation specialists have a role as advocates for social and community engagement for children with physical limitations. Providing families with information on community-based opportunities, and the strategies and environmental modifications available may increase social participation for our youth growing up with a neuromuscular disorder.

Entities:  

Keywords:  Duchenne muscular dystrophy; functional outcomes; participation; social engagement; strength outcomes

Mesh:

Year:  2014        PMID: 24499260      PMCID: PMC4125555          DOI: 10.3109/09638288.2014.883444

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  22 in total

1.  Psychometric evaluation of the Participation and Environment Measure for Children and Youth.

Authors:  Wendy Coster; Gary Bedell; Mary Law; Mary Alunkal Khetani; Rachel Teplicky; Kendra Liljenquist; Kara Gleason; Ying-Chia Kao
Journal:  Dev Med Child Neurol       Date:  2011-11       Impact factor: 5.449

2.  Difficult to measure constructs: conceptual and methodological issues concerning participation and environmental factors.

Authors:  Gale Whiteneck; Marcel P Dijkers
Journal:  Arch Phys Med Rehabil       Date:  2009-11       Impact factor: 3.966

Review 3.  Review of occupational therapy research in the practice area of children and youth.

Authors:  Roxanna M Bendixen; Consuelo M Kreider
Journal:  Am J Occup Ther       Date:  2011 May-Jun

4.  Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.

Authors:  Sunita Mathur; Donovan J Lott; Claudia Senesac; Sean A Germain; Ravneet S Vohra; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

5.  Challenges in drug development for muscle disease: a stakeholders' meeting.

Authors:  Jerry R Mendell; Cristina Csimma; Craig M McDonald; Diana M Escolar; Scott Janis; John D Porter; Sharon E Hesterlee; R Rodney Howell
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

6.  Measuring children's participation in recreation and leisure activities: construct validation of the CAPE and PAC.

Authors:  G A King; M Law; S King; P Hurley; S Hanna; M Kertoy; P Rosenbaum
Journal:  Child Care Health Dev       Date:  2007-01       Impact factor: 2.508

7.  ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders.

Authors:  Laure Vandervelde; Peter Y K Van den Bergh; Nathalie Goemans; Jean-Louis Thonnard
Journal:  Neuromuscul Disord       Date:  2007-04-11       Impact factor: 4.296

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

9.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.

Authors:  Tishya A L Wren; Stefan Bluml; Linda Tseng-Ong; Vicente Gilsanz
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

10.  Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health.

Authors:  Roxanna M Bendixen; Claudia Senesac; Donovan J Lott; Krista Vandenborne
Journal:  Health Qual Life Outcomes       Date:  2012-05-22       Impact factor: 3.186

View more
  7 in total

1.  Social networks and participation with others for youth with learning, attention, and autism spectrum disorders.

Authors:  Consuelo M Kreider; Roxanna M Bendixen; Mary Ellen Young; Stephanie M Prudencio; Christopher McCarty; William C Mann
Journal:  Can J Occup Ther       Date:  2015-06-15       Impact factor: 1.614

2.  Occurrence of symptoms in different stages of Duchenne muscular dystrophy and their impact on social participation.

Authors:  Saskia L S Houwen-van Opstal; Lotte Heutinck; Merel Jansen; Yvonne D Krom; Edith H C Cup; Jos G M Hendriksen; Michel A A P Willemsen; Jan J G M Verschuuren; Erik H Niks; Imelda J M de Groot
Journal:  Muscle Nerve       Date:  2021-09-09       Impact factor: 3.852

3.  Gait characteristics in a canine model of X-linked myotubular myopathy.

Authors:  Melissa A Goddard; Emily Burlingame; Alan H Beggs; Anna Buj-Bello; Martin K Childers; Anthony P Marsh; Valerie E Kelly
Journal:  J Neurol Sci       Date:  2014-08-29       Impact factor: 3.181

Review 4.  The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.

Authors:  S Ryder; R M Leadley; N Armstrong; M Westwood; S de Kock; T Butt; M Jain; J Kleijnen
Journal:  Orphanet J Rare Dis       Date:  2017-04-26       Impact factor: 4.123

5.  Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol.

Authors:  Philip A Powell; Jill Carlton; Donna Rowen; John E Brazier
Journal:  BMJ Open       Date:  2019-03-09       Impact factor: 2.692

6.  User-centred assistive SystEm for arm Functions in neUromuscuLar subjects (USEFUL): a randomized controlled study.

Authors:  Valeria Longatelli; Alberto Antonietti; Emilia Biffi; Eleonora Diella; Maria Grazia D'Angelo; Mauro Rossini; Franco Molteni; Marco Bocciolone; Alessandra Pedrocchi; Marta Gandolla
Journal:  J Neuroeng Rehabil       Date:  2021-01-06       Impact factor: 4.262

7.  Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy.

Authors:  Camila Miliani Capelini; Talita Dias da Silva; James Tonks; Suzanna Watson; Mayra Priscila Boscolo Alvarez; Lilian Del Ciello de Menezes; Francis Meire Favero; Fátima Aparecida Caromano; Thais Massetti; Carlos Bandeira de Mello Monteiro
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-18       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.